Hanmi Pharm. Co., Ltd. (KRX:128940)
483,000
-8,500 (-1.73%)
Apr 29, 2026, 3:30 PM KST
Hanmi Pharm. Revenue
In the year 2025, Hanmi Pharm. had annual revenue of 1.55T KRW with 3.48% growth. Hanmi Pharm. had revenue of 432.96B in the quarter ending December 31, 2025, with 23.14% growth.
Revenue
1,547.53B
Revenue Growth
+3.48%
P/S Ratio
4.03
Revenue / Employee
644.80M
Employees
2,400
Market Cap
6,232.33B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1,547.53B | 52.03B | 3.48% |
| Dec 31, 2024 | 1,495.50B | 4.61B | 0.31% |
| Dec 31, 2023 | 1,490.89B | 159.34B | 11.97% |
| Dec 31, 2022 | 1,331.55B | 128.36B | 10.67% |
| Dec 31, 2021 | 1,203.19B | 127.33B | 11.84% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Yuhan | 2,186.64B |
| Hanall Biopharma | 155.18B |
| Celltrion Pharm | 274.73B |
| Daewoong Pharmaceutical | 1,570.89B |
| GC Biopharma | 1,991.28B |
| Chong Kun Dang Pharmaceutical | 1,692.40B |
| DongKook Pharmaceutical | 926.88B |
| Daewoong | 2,068.37B |